nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Mesalazine—PPARG—thyroid cancer	0.00951	0.703	CrCbGaD
Carbidopa—Insomnia—Vandetanib—thyroid cancer	0.00421	0.00433	CcSEcCtD
Carbidopa—Paraesthesia—Vandetanib—thyroid cancer	0.00418	0.0043	CcSEcCtD
Carbidopa—Blister—Doxorubicin—thyroid cancer	0.00418	0.0043	CcSEcCtD
Carbidopa—DDC—Dopaminergic Neurogenesis—RET—thyroid cancer	0.00416	0.289	CbGpPWpGaD
Carbidopa—Dyspnoea—Vandetanib—thyroid cancer	0.00415	0.00427	CcSEcCtD
Carbidopa—Flushing—Sorafenib—thyroid cancer	0.0041	0.00422	CcSEcCtD
Carbidopa—Dyspepsia—Vandetanib—thyroid cancer	0.0041	0.00422	CcSEcCtD
Carbidopa—Decreased appetite—Vandetanib—thyroid cancer	0.00405	0.00416	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00402	0.00414	CcSEcCtD
Carbidopa—Fatigue—Vandetanib—thyroid cancer	0.00401	0.00413	CcSEcCtD
Carbidopa—Mesalazine—PTGS2—thyroid cancer	0.00401	0.297	CrCbGaD
Carbidopa—Pain—Vandetanib—thyroid cancer	0.00398	0.0041	CcSEcCtD
Carbidopa—Constipation—Vandetanib—thyroid cancer	0.00398	0.0041	CcSEcCtD
Carbidopa—Dysphonia—Epirubicin—thyroid cancer	0.00395	0.00407	CcSEcCtD
Carbidopa—Alopecia—Sorafenib—thyroid cancer	0.00391	0.00402	CcSEcCtD
Carbidopa—Mental disorder—Sorafenib—thyroid cancer	0.00387	0.00398	CcSEcCtD
Carbidopa—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00381	0.00392	CcSEcCtD
Carbidopa—Dysgeusia—Sorafenib—thyroid cancer	0.00377	0.00388	CcSEcCtD
Carbidopa—Extravasation—Epirubicin—thyroid cancer	0.00373	0.00384	CcSEcCtD
Carbidopa—Muscle spasms—Sorafenib—thyroid cancer	0.0037	0.00381	CcSEcCtD
Carbidopa—Abdominal pain—Vandetanib—thyroid cancer	0.00368	0.00379	CcSEcCtD
Carbidopa—Body temperature increased—Vandetanib—thyroid cancer	0.00368	0.00379	CcSEcCtD
Carbidopa—Dysphonia—Doxorubicin—thyroid cancer	0.00366	0.00376	CcSEcCtD
Carbidopa—Anaemia—Sorafenib—thyroid cancer	0.00356	0.00366	CcSEcCtD
Carbidopa—Angioedema—Sorafenib—thyroid cancer	0.00352	0.00362	CcSEcCtD
Carbidopa—Dyskinesia—Epirubicin—thyroid cancer	0.00346	0.00356	CcSEcCtD
Carbidopa—Syncope—Sorafenib—thyroid cancer	0.00345	0.00355	CcSEcCtD
Carbidopa—Extravasation—Doxorubicin—thyroid cancer	0.00345	0.00355	CcSEcCtD
Carbidopa—Leukopenia—Sorafenib—thyroid cancer	0.00344	0.00354	CcSEcCtD
Carbidopa—Loss of consciousness—Sorafenib—thyroid cancer	0.00338	0.00348	CcSEcCtD
Carbidopa—Cough—Sorafenib—thyroid cancer	0.00336	0.00345	CcSEcCtD
Carbidopa—Asthenia—Vandetanib—thyroid cancer	0.00334	0.00344	CcSEcCtD
Carbidopa—Gait disturbance—Epirubicin—thyroid cancer	0.00333	0.00343	CcSEcCtD
Carbidopa—Hypertension—Sorafenib—thyroid cancer	0.00332	0.00342	CcSEcCtD
Carbidopa—Pruritus—Vandetanib—thyroid cancer	0.00329	0.00339	CcSEcCtD
Carbidopa—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00329	0.00339	CcSEcCtD
Carbidopa—Hiccups—Epirubicin—thyroid cancer	0.00325	0.00335	CcSEcCtD
Carbidopa—DDC—Amine-derived hormones—SLC5A5—thyroid cancer	0.00323	0.225	CbGpPWpGaD
Carbidopa—Dry mouth—Sorafenib—thyroid cancer	0.0032	0.0033	CcSEcCtD
Carbidopa—Dyskinesia—Doxorubicin—thyroid cancer	0.0032	0.0033	CcSEcCtD
Carbidopa—Diarrhoea—Vandetanib—thyroid cancer	0.00319	0.00328	CcSEcCtD
Carbidopa—Salivary hypersecretion—Epirubicin—thyroid cancer	0.00316	0.00325	CcSEcCtD
Carbidopa—Infection—Sorafenib—thyroid cancer	0.00312	0.00321	CcSEcCtD
Carbidopa—Shock—Sorafenib—thyroid cancer	0.00309	0.00318	CcSEcCtD
Carbidopa—Gait disturbance—Doxorubicin—thyroid cancer	0.00308	0.00317	CcSEcCtD
Carbidopa—Dizziness—Vandetanib—thyroid cancer	0.00308	0.00317	CcSEcCtD
Carbidopa—Thrombocytopenia—Sorafenib—thyroid cancer	0.00308	0.00316	CcSEcCtD
Carbidopa—Blood urea increased—Epirubicin—thyroid cancer	0.00307	0.00316	CcSEcCtD
Carbidopa—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00305	0.00313	CcSEcCtD
Carbidopa—Hiccups—Doxorubicin—thyroid cancer	0.00301	0.0031	CcSEcCtD
Carbidopa—Anorexia—Sorafenib—thyroid cancer	0.00299	0.00308	CcSEcCtD
Carbidopa—Vomiting—Vandetanib—thyroid cancer	0.00296	0.00305	CcSEcCtD
Carbidopa—Rash—Vandetanib—thyroid cancer	0.00294	0.00302	CcSEcCtD
Carbidopa—Dermatitis—Vandetanib—thyroid cancer	0.00293	0.00302	CcSEcCtD
Carbidopa—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.00292	0.00301	CcSEcCtD
Carbidopa—Headache—Vandetanib—thyroid cancer	0.00292	0.003	CcSEcCtD
Carbidopa—Blood urea increased—Doxorubicin—thyroid cancer	0.00284	0.00292	CcSEcCtD
Carbidopa—Dyspnoea—Sorafenib—thyroid cancer	0.0028	0.00288	CcSEcCtD
Carbidopa—Nausea—Vandetanib—thyroid cancer	0.00277	0.00285	CcSEcCtD
Carbidopa—Dyspepsia—Sorafenib—thyroid cancer	0.00276	0.00284	CcSEcCtD
Carbidopa—Phlebitis—Epirubicin—thyroid cancer	0.00274	0.00282	CcSEcCtD
Carbidopa—Decreased appetite—Sorafenib—thyroid cancer	0.00273	0.00281	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00271	0.00279	CcSEcCtD
Carbidopa—Fatigue—Sorafenib—thyroid cancer	0.00271	0.00279	CcSEcCtD
Carbidopa—Pain—Sorafenib—thyroid cancer	0.00269	0.00276	CcSEcCtD
Carbidopa—Constipation—Sorafenib—thyroid cancer	0.00269	0.00276	CcSEcCtD
Carbidopa—Vascular purpura—Epirubicin—thyroid cancer	0.00264	0.00272	CcSEcCtD
Carbidopa—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00257	0.00264	CcSEcCtD
Carbidopa—Phlebitis—Doxorubicin—thyroid cancer	0.00254	0.00261	CcSEcCtD
Carbidopa—Hot flush—Epirubicin—thyroid cancer	0.00252	0.0026	CcSEcCtD
Carbidopa—Menopausal symptoms—Epirubicin—thyroid cancer	0.0025	0.00257	CcSEcCtD
Carbidopa—Urticaria—Sorafenib—thyroid cancer	0.0025	0.00257	CcSEcCtD
Carbidopa—Abdominal pain—Sorafenib—thyroid cancer	0.00248	0.00255	CcSEcCtD
Carbidopa—Body temperature increased—Sorafenib—thyroid cancer	0.00248	0.00255	CcSEcCtD
Carbidopa—Dermatitis bullous—Epirubicin—thyroid cancer	0.00247	0.00254	CcSEcCtD
Carbidopa—Purpura—Epirubicin—thyroid cancer	0.00245	0.00252	CcSEcCtD
Carbidopa—Vascular purpura—Doxorubicin—thyroid cancer	0.00244	0.00251	CcSEcCtD
Carbidopa—Hyponatraemia—Epirubicin—thyroid cancer	0.00237	0.00244	CcSEcCtD
Carbidopa—Diplopia—Epirubicin—thyroid cancer	0.00236	0.00243	CcSEcCtD
Carbidopa—Pain in extremity—Epirubicin—thyroid cancer	0.00236	0.00243	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00236	0.00243	CcSEcCtD
Carbidopa—Hot flush—Doxorubicin—thyroid cancer	0.00234	0.0024	CcSEcCtD
Carbidopa—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00232	0.00238	CcSEcCtD
Carbidopa—Hypersensitivity—Sorafenib—thyroid cancer	0.00231	0.00238	CcSEcCtD
Carbidopa—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00229	0.00235	CcSEcCtD
Carbidopa—Purpura—Doxorubicin—thyroid cancer	0.00227	0.00233	CcSEcCtD
Carbidopa—Asthenia—Sorafenib—thyroid cancer	0.00225	0.00232	CcSEcCtD
Carbidopa—Pruritus—Sorafenib—thyroid cancer	0.00222	0.00229	CcSEcCtD
Carbidopa—Ataxia—Epirubicin—thyroid cancer	0.00222	0.00228	CcSEcCtD
Carbidopa—Blood creatinine increased—Epirubicin—thyroid cancer	0.00221	0.00228	CcSEcCtD
Carbidopa—Hyponatraemia—Doxorubicin—thyroid cancer	0.00219	0.00226	CcSEcCtD
Carbidopa—Pain in extremity—Doxorubicin—thyroid cancer	0.00219	0.00225	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00219	0.00225	CcSEcCtD
Carbidopa—Diplopia—Doxorubicin—thyroid cancer	0.00219	0.00225	CcSEcCtD
Carbidopa—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00216	0.00222	CcSEcCtD
Carbidopa—Diarrhoea—Sorafenib—thyroid cancer	0.00215	0.00221	CcSEcCtD
Carbidopa—Nasopharyngitis—Epirubicin—thyroid cancer	0.00211	0.00217	CcSEcCtD
Carbidopa—Gastritis—Epirubicin—thyroid cancer	0.00209	0.00215	CcSEcCtD
Carbidopa—Dizziness—Sorafenib—thyroid cancer	0.00208	0.00214	CcSEcCtD
Carbidopa—Ataxia—Doxorubicin—thyroid cancer	0.00205	0.00211	CcSEcCtD
Carbidopa—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00205	0.00211	CcSEcCtD
Carbidopa—Dysphagia—Epirubicin—thyroid cancer	0.00204	0.0021	CcSEcCtD
Carbidopa—Vomiting—Sorafenib—thyroid cancer	0.002	0.00205	CcSEcCtD
Carbidopa—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.002	0.00205	CcSEcCtD
Carbidopa—Rash—Sorafenib—thyroid cancer	0.00198	0.00204	CcSEcCtD
Carbidopa—Dermatitis—Sorafenib—thyroid cancer	0.00198	0.00204	CcSEcCtD
Carbidopa—Headache—Sorafenib—thyroid cancer	0.00197	0.00202	CcSEcCtD
Carbidopa—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00195	0.00201	CcSEcCtD
Carbidopa—Gastritis—Doxorubicin—thyroid cancer	0.00193	0.00199	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.0019	0.00195	CcSEcCtD
Carbidopa—Dysphagia—Doxorubicin—thyroid cancer	0.00189	0.00194	CcSEcCtD
Carbidopa—Pollakiuria—Epirubicin—thyroid cancer	0.00189	0.00194	CcSEcCtD
Carbidopa—Nausea—Sorafenib—thyroid cancer	0.00187	0.00192	CcSEcCtD
Carbidopa—Weight increased—Epirubicin—thyroid cancer	0.00186	0.00191	CcSEcCtD
Carbidopa—Weight decreased—Epirubicin—thyroid cancer	0.00185	0.0019	CcSEcCtD
Carbidopa—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00178	0.00184	CcSEcCtD
Carbidopa—Urinary tract infection—Epirubicin—thyroid cancer	0.00177	0.00182	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00176	0.00181	CcSEcCtD
Carbidopa—Pollakiuria—Doxorubicin—thyroid cancer	0.00174	0.00179	CcSEcCtD
Carbidopa—Weight increased—Doxorubicin—thyroid cancer	0.00172	0.00177	CcSEcCtD
Carbidopa—Weight decreased—Doxorubicin—thyroid cancer	0.00171	0.00176	CcSEcCtD
Carbidopa—Agranulocytosis—Epirubicin—thyroid cancer	0.0017	0.00175	CcSEcCtD
Carbidopa—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00165	0.0017	CcSEcCtD
Carbidopa—Haemoglobin—Epirubicin—thyroid cancer	0.00164	0.00169	CcSEcCtD
Carbidopa—Rhinitis—Epirubicin—thyroid cancer	0.00164	0.00168	CcSEcCtD
Carbidopa—Urinary tract infection—Doxorubicin—thyroid cancer	0.00164	0.00168	CcSEcCtD
Carbidopa—Haemorrhage—Epirubicin—thyroid cancer	0.00163	0.00168	CcSEcCtD
Carbidopa—Hypoaesthesia—Epirubicin—thyroid cancer	0.00163	0.00167	CcSEcCtD
Carbidopa—Urinary tract disorder—Epirubicin—thyroid cancer	0.00161	0.00166	CcSEcCtD
Carbidopa—Urethral disorder—Epirubicin—thyroid cancer	0.0016	0.00165	CcSEcCtD
Carbidopa—Agranulocytosis—Doxorubicin—thyroid cancer	0.00157	0.00162	CcSEcCtD
Carbidopa—Haemoglobin—Doxorubicin—thyroid cancer	0.00152	0.00156	CcSEcCtD
Carbidopa—Flushing—Epirubicin—thyroid cancer	0.00152	0.00156	CcSEcCtD
Carbidopa—Rhinitis—Doxorubicin—thyroid cancer	0.00152	0.00156	CcSEcCtD
Carbidopa—Haemorrhage—Doxorubicin—thyroid cancer	0.00151	0.00156	CcSEcCtD
Carbidopa—Hypoaesthesia—Doxorubicin—thyroid cancer	0.0015	0.00155	CcSEcCtD
Carbidopa—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00149	0.00154	CcSEcCtD
Carbidopa—Urethral disorder—Doxorubicin—thyroid cancer	0.00148	0.00152	CcSEcCtD
Carbidopa—Alopecia—Epirubicin—thyroid cancer	0.00144	0.00149	CcSEcCtD
Carbidopa—Mental disorder—Epirubicin—thyroid cancer	0.00143	0.00147	CcSEcCtD
Carbidopa—Flushing—Doxorubicin—thyroid cancer	0.0014	0.00144	CcSEcCtD
Carbidopa—Flatulence—Epirubicin—thyroid cancer	0.0014	0.00144	CcSEcCtD
Carbidopa—Tension—Epirubicin—thyroid cancer	0.0014	0.00144	CcSEcCtD
Carbidopa—Dysgeusia—Epirubicin—thyroid cancer	0.00139	0.00143	CcSEcCtD
Carbidopa—Nervousness—Epirubicin—thyroid cancer	0.00138	0.00142	CcSEcCtD
Carbidopa—Back pain—Epirubicin—thyroid cancer	0.00138	0.00142	CcSEcCtD
Carbidopa—Muscle spasms—Epirubicin—thyroid cancer	0.00137	0.00141	CcSEcCtD
Carbidopa—Vision blurred—Epirubicin—thyroid cancer	0.00134	0.00138	CcSEcCtD
Carbidopa—Alopecia—Doxorubicin—thyroid cancer	0.00134	0.00137	CcSEcCtD
Carbidopa—Mental disorder—Doxorubicin—thyroid cancer	0.00132	0.00136	CcSEcCtD
Carbidopa—Ill-defined disorder—Epirubicin—thyroid cancer	0.00132	0.00136	CcSEcCtD
Carbidopa—Anaemia—Epirubicin—thyroid cancer	0.00131	0.00135	CcSEcCtD
Carbidopa—Agitation—Epirubicin—thyroid cancer	0.00131	0.00134	CcSEcCtD
Carbidopa—Flatulence—Doxorubicin—thyroid cancer	0.0013	0.00133	CcSEcCtD
Carbidopa—Tension—Doxorubicin—thyroid cancer	0.00129	0.00133	CcSEcCtD
Carbidopa—Dysgeusia—Doxorubicin—thyroid cancer	0.00129	0.00133	CcSEcCtD
Carbidopa—Malaise—Epirubicin—thyroid cancer	0.00128	0.00132	CcSEcCtD
Carbidopa—Nervousness—Doxorubicin—thyroid cancer	0.00128	0.00131	CcSEcCtD
Carbidopa—Syncope—Epirubicin—thyroid cancer	0.00128	0.00131	CcSEcCtD
Carbidopa—Leukopenia—Epirubicin—thyroid cancer	0.00127	0.00131	CcSEcCtD
Carbidopa—Back pain—Doxorubicin—thyroid cancer	0.00127	0.00131	CcSEcCtD
Carbidopa—Muscle spasms—Doxorubicin—thyroid cancer	0.00127	0.0013	CcSEcCtD
Carbidopa—Palpitations—Epirubicin—thyroid cancer	0.00126	0.00129	CcSEcCtD
Carbidopa—Loss of consciousness—Epirubicin—thyroid cancer	0.00125	0.00129	CcSEcCtD
Carbidopa—Cough—Epirubicin—thyroid cancer	0.00124	0.00128	CcSEcCtD
Carbidopa—Vision blurred—Doxorubicin—thyroid cancer	0.00124	0.00128	CcSEcCtD
Carbidopa—Convulsion—Epirubicin—thyroid cancer	0.00123	0.00127	CcSEcCtD
Carbidopa—Hypertension—Epirubicin—thyroid cancer	0.00123	0.00126	CcSEcCtD
Carbidopa—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00122	0.00126	CcSEcCtD
Carbidopa—Anaemia—Doxorubicin—thyroid cancer	0.00122	0.00125	CcSEcCtD
Carbidopa—Chest pain—Epirubicin—thyroid cancer	0.00121	0.00125	CcSEcCtD
Carbidopa—Agitation—Doxorubicin—thyroid cancer	0.00121	0.00124	CcSEcCtD
Carbidopa—Anxiety—Epirubicin—thyroid cancer	0.00121	0.00124	CcSEcCtD
Carbidopa—Discomfort—Epirubicin—thyroid cancer	0.0012	0.00123	CcSEcCtD
Carbidopa—Malaise—Doxorubicin—thyroid cancer	0.00119	0.00122	CcSEcCtD
Carbidopa—Dry mouth—Epirubicin—thyroid cancer	0.00118	0.00122	CcSEcCtD
Carbidopa—Syncope—Doxorubicin—thyroid cancer	0.00118	0.00121	CcSEcCtD
Carbidopa—Leukopenia—Doxorubicin—thyroid cancer	0.00118	0.00121	CcSEcCtD
Carbidopa—Confusional state—Epirubicin—thyroid cancer	0.00117	0.0012	CcSEcCtD
Carbidopa—Palpitations—Doxorubicin—thyroid cancer	0.00116	0.0012	CcSEcCtD
Carbidopa—Oedema—Epirubicin—thyroid cancer	0.00116	0.00119	CcSEcCtD
Carbidopa—Loss of consciousness—Doxorubicin—thyroid cancer	0.00116	0.00119	CcSEcCtD
Carbidopa—Infection—Epirubicin—thyroid cancer	0.00115	0.00119	CcSEcCtD
Carbidopa—Cough—Doxorubicin—thyroid cancer	0.00115	0.00118	CcSEcCtD
Carbidopa—Shock—Epirubicin—thyroid cancer	0.00114	0.00117	CcSEcCtD
Carbidopa—Convulsion—Doxorubicin—thyroid cancer	0.00114	0.00117	CcSEcCtD
Carbidopa—Thrombocytopenia—Epirubicin—thyroid cancer	0.00114	0.00117	CcSEcCtD
Carbidopa—Hypertension—Doxorubicin—thyroid cancer	0.00114	0.00117	CcSEcCtD
Carbidopa—Hyperhidrosis—Epirubicin—thyroid cancer	0.00112	0.00115	CcSEcCtD
Carbidopa—Chest pain—Doxorubicin—thyroid cancer	0.00112	0.00115	CcSEcCtD
Carbidopa—Anxiety—Doxorubicin—thyroid cancer	0.00112	0.00115	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00111	0.0773	CbGpPWpGaD
Carbidopa—Discomfort—Doxorubicin—thyroid cancer	0.00111	0.00114	CcSEcCtD
Carbidopa—Anorexia—Epirubicin—thyroid cancer	0.00111	0.00114	CcSEcCtD
Carbidopa—Dry mouth—Doxorubicin—thyroid cancer	0.0011	0.00113	CcSEcCtD
Carbidopa—Hypotension—Epirubicin—thyroid cancer	0.00108	0.00112	CcSEcCtD
Carbidopa—Confusional state—Doxorubicin—thyroid cancer	0.00108	0.00111	CcSEcCtD
Carbidopa—Oedema—Doxorubicin—thyroid cancer	0.00107	0.0011	CcSEcCtD
Carbidopa—Infection—Doxorubicin—thyroid cancer	0.00107	0.0011	CcSEcCtD
Carbidopa—Shock—Doxorubicin—thyroid cancer	0.00106	0.00109	CcSEcCtD
Carbidopa—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00105	0.00108	CcSEcCtD
Carbidopa—Insomnia—Epirubicin—thyroid cancer	0.00105	0.00108	CcSEcCtD
Carbidopa—Paraesthesia—Epirubicin—thyroid cancer	0.00104	0.00107	CcSEcCtD
Carbidopa—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00104	0.00107	CcSEcCtD
Carbidopa—Dyspnoea—Epirubicin—thyroid cancer	0.00103	0.00106	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00103	0.0718	CbGpPWpGaD
Carbidopa—Somnolence—Epirubicin—thyroid cancer	0.00103	0.00106	CcSEcCtD
Carbidopa—Anorexia—Doxorubicin—thyroid cancer	0.00102	0.00105	CcSEcCtD
Carbidopa—Dyspepsia—Epirubicin—thyroid cancer	0.00102	0.00105	CcSEcCtD
Carbidopa—Decreased appetite—Epirubicin—thyroid cancer	0.00101	0.00104	CcSEcCtD
Carbidopa—Hypotension—Doxorubicin—thyroid cancer	0.001	0.00103	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.001	0.00103	CcSEcCtD
Carbidopa—Fatigue—Epirubicin—thyroid cancer	0.001	0.00103	CcSEcCtD
Carbidopa—Pain—Epirubicin—thyroid cancer	0.000993	0.00102	CcSEcCtD
Carbidopa—Constipation—Epirubicin—thyroid cancer	0.000993	0.00102	CcSEcCtD
Carbidopa—Insomnia—Doxorubicin—thyroid cancer	0.000971	0.000999	CcSEcCtD
Carbidopa—Paraesthesia—Doxorubicin—thyroid cancer	0.000964	0.000992	CcSEcCtD
Carbidopa—Dyspnoea—Doxorubicin—thyroid cancer	0.000958	0.000985	CcSEcCtD
Carbidopa—Feeling abnormal—Epirubicin—thyroid cancer	0.000957	0.000984	CcSEcCtD
Carbidopa—Somnolence—Doxorubicin—thyroid cancer	0.000955	0.000982	CcSEcCtD
Carbidopa—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000949	0.000976	CcSEcCtD
Carbidopa—Dyspepsia—Doxorubicin—thyroid cancer	0.000945	0.000973	CcSEcCtD
Carbidopa—Decreased appetite—Doxorubicin—thyroid cancer	0.000934	0.00096	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000927	0.000954	CcSEcCtD
Carbidopa—Fatigue—Doxorubicin—thyroid cancer	0.000926	0.000953	CcSEcCtD
Carbidopa—Urticaria—Epirubicin—thyroid cancer	0.000922	0.000949	CcSEcCtD
Carbidopa—Pain—Doxorubicin—thyroid cancer	0.000918	0.000945	CcSEcCtD
Carbidopa—Constipation—Doxorubicin—thyroid cancer	0.000918	0.000945	CcSEcCtD
Carbidopa—Body temperature increased—Epirubicin—thyroid cancer	0.000918	0.000944	CcSEcCtD
Carbidopa—Abdominal pain—Epirubicin—thyroid cancer	0.000918	0.000944	CcSEcCtD
Carbidopa—Feeling abnormal—Doxorubicin—thyroid cancer	0.000885	0.00091	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—NKX2-1—thyroid cancer	0.000885	0.0615	CbGpPWpGaD
Carbidopa—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000878	0.000903	CcSEcCtD
Carbidopa—Hypersensitivity—Epirubicin—thyroid cancer	0.000855	0.00088	CcSEcCtD
Carbidopa—Urticaria—Doxorubicin—thyroid cancer	0.000853	0.000878	CcSEcCtD
Carbidopa—Abdominal pain—Doxorubicin—thyroid cancer	0.000849	0.000873	CcSEcCtD
Carbidopa—Body temperature increased—Doxorubicin—thyroid cancer	0.000849	0.000873	CcSEcCtD
Carbidopa—Asthenia—Epirubicin—thyroid cancer	0.000833	0.000857	CcSEcCtD
Carbidopa—Pruritus—Epirubicin—thyroid cancer	0.000821	0.000845	CcSEcCtD
Carbidopa—Diarrhoea—Epirubicin—thyroid cancer	0.000794	0.000817	CcSEcCtD
Carbidopa—Hypersensitivity—Doxorubicin—thyroid cancer	0.000791	0.000814	CcSEcCtD
Carbidopa—Asthenia—Doxorubicin—thyroid cancer	0.000771	0.000793	CcSEcCtD
Carbidopa—Dizziness—Epirubicin—thyroid cancer	0.000768	0.00079	CcSEcCtD
Carbidopa—Pruritus—Doxorubicin—thyroid cancer	0.00076	0.000782	CcSEcCtD
Carbidopa—Vomiting—Epirubicin—thyroid cancer	0.000738	0.000759	CcSEcCtD
Carbidopa—Diarrhoea—Doxorubicin—thyroid cancer	0.000735	0.000756	CcSEcCtD
Carbidopa—Rash—Epirubicin—thyroid cancer	0.000732	0.000753	CcSEcCtD
Carbidopa—Dermatitis—Epirubicin—thyroid cancer	0.000731	0.000752	CcSEcCtD
Carbidopa—Headache—Epirubicin—thyroid cancer	0.000727	0.000748	CcSEcCtD
Carbidopa—Dizziness—Doxorubicin—thyroid cancer	0.00071	0.000731	CcSEcCtD
Carbidopa—Nausea—Epirubicin—thyroid cancer	0.000689	0.000709	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000687	0.0477	CbGpPWpGaD
Carbidopa—Vomiting—Doxorubicin—thyroid cancer	0.000683	0.000702	CcSEcCtD
Carbidopa—Rash—Doxorubicin—thyroid cancer	0.000677	0.000697	CcSEcCtD
Carbidopa—Dermatitis—Doxorubicin—thyroid cancer	0.000677	0.000696	CcSEcCtD
Carbidopa—Headache—Doxorubicin—thyroid cancer	0.000673	0.000692	CcSEcCtD
Carbidopa—Nausea—Doxorubicin—thyroid cancer	0.000638	0.000656	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000543	0.0377	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—SLC5A5—thyroid cancer	0.00045	0.0313	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000326	0.0227	CbGpPWpGaD
Carbidopa—DDC—Metabolism—MINPP1—thyroid cancer	0.000298	0.0207	CbGpPWpGaD
Carbidopa—DDC—Metabolism—NDUFA13—thyroid cancer	0.000254	0.0176	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CHST14—thyroid cancer	0.000239	0.0166	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—PPARG—thyroid cancer	0.000226	0.0157	CbGpPWpGaD
Carbidopa—DDC—Metabolism—HPGD—thyroid cancer	0.000192	0.0134	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—PTEN—thyroid cancer	0.000155	0.0108	CbGpPWpGaD
Carbidopa—DDC—Metabolism—TPR—thyroid cancer	0.00011	0.00767	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PRKAR1A—thyroid cancer	0.000109	0.00755	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—TP53—thyroid cancer	0.000106	0.00737	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SLC5A5—thyroid cancer	8.27e-05	0.00574	CbGpPWpGaD
Carbidopa—DDC—Metabolism—RXRA—thyroid cancer	6.94e-05	0.00483	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PPARG—thyroid cancer	4.38e-05	0.00305	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PTGS2—thyroid cancer	3.45e-05	0.0024	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PTEN—thyroid cancer	3.01e-05	0.00209	CbGpPWpGaD
Carbidopa—DDC—Metabolism—AKT1—thyroid cancer	1.73e-05	0.0012	CbGpPWpGaD
